Synthesis by Peptide Structure

Creative Biolabs is an industry leader in advanced peptide engineering, dedicated to overcoming the inherent challenges of peptide stability, solubility, and bioavailability. Our platform integrates advanced synthetic chemistry, rigorous quality control, and deep expertise in structural modifications to deliver bioactive peptides for your cutting-edge in vitro research and cosmetic R&D.

Browse our advanced structural peptide synthesis capabilities, ranging from fundamental linear chains to highly complex macrocyclic architectures.

Standard Linear Peptides

Our standard linear peptide synthesis service provides efficient production of foundational sequential amino acid chains. Used in baseline formulation testing, it helps clients synthesize high-purity linear sequences for applications in dermatological research and cosmetic R&D.

Learn More →

Cyclic Peptides

We specialize in cyclic peptide synthesis, providing structurally rigid molecules with enhanced enzymatic resistance. This service helps clients overcome bioavailability challenges in complex in vitro models, aiding in their applications in advanced skin delivery systems and functional cosmetic research.

Learn More →

Peptides with Unnatural Amino Acids

Our unnatural amino acid peptide synthesis service offers advanced functional sequences incorporating specialized synthetic residues to evade rapid proteolytic cleavage. Used in half-life extension studies, it helps clients customize modified peptides for applications in rigorous formulation development and bioactivity research.

Learn More →

Long & Complex Peptides

We specialize in long-chain and complex peptide synthesis, providing intricate macromolecular assemblies exceeding 40 amino acids that mimic larger human growth factors. This service helps clients overcome the challenges of convergent synthesis, aiding in their applications in advanced cellular signaling research and next-generation cosmetic development.

Learn More →

Online Inquiry
Only available to researchers and companies, not for individuals.